Country: United States
Language: English
Source: NLM (National Library of Medicine)
POVIDONE-IODINE (UNII: 85H0HZU99M) (IODINE - UNII:9679TC07X4)
OASIS TRADING
VAGINAL
OTC DRUG
Local treatment in the following cases: Candidate vaginitis, trichomonas vaginitis, non-specific and mixed infection, preoperative pre-operative treatment of obstetrics and gynecology, local cleaning and release Put 200 mg deep into the vagina once a day. It is advisable to insert it in the evening before bedtime. To increase or decrease appropriately according to age and symptoms.
unapproved drug other
GYNO-BETADINE- POVIDONE IODINE SUPPOSITORY OASIS TRADING _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- POVIDONE-IODINE Local treatment in the following cases: Candidate vaginitis, trichomonas vaginitis, non-specific and mixed infection, preoperative pre-operative treatment of obstetrics and gynecology, local cleaning and release Keep out of reach of children Put 200 mg deep into the vagina once a day. It is advisable to insert it in the evening before bedtime. To increase or decrease appropriately according to age and symptoms. DO NOT USE in the eyes as a first aid antiseptic longer than one week on individuals who are allergic or sensitive to iodine over large areas of the body KEEP OUT OF REACH OF CHILDREN. IF SWALLOWED, get medical help or contact a Poison Control Center right away. POLYETHYLENE GLYCOL 1540 For vaginal use only GYNO-BETADINE povidone iodine suppository PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:726 8 9 -0 0 42 ROUTE OF ADMINISTRATION VAGINAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH PO VIDO NE-IO DINE (UNII: 8 5H0 HZU9 9 M) (IODINE - UNII:9 6 79 TC0 7X4) IODINE 20 0 mg INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH PO LYETHYLENE GLYCO L 150 0 (UNII: 1212Z7S33A) OASIS TRADING PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:726 8 9 -0 0 42-1 10 in 1 BLISTER PACK; Type 0 : No t a Co mbinatio n Pro duct 11/21/20 18 MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE TING START DATE MARKE TING END DATE unappro ved drug o ther 11/21/20 18 LABELER - OASIS T RADING (689991468) REGISTRANT - OASIS T RADING (689991468) ESTABLISHMENT NAME AD D RE S S ID/FEI BUSINE SS OPE RATIONS OASIS TRADING 6 8 9 9 9 146 8 manufacture(726 8 9 -0 0 42) , relabel(726 8 9 -0 0 42) Revised: 3/2019 Read the complete document